Takeda’s Actos Has Same Heart Risk as Glaxo’s Avandia
This article is for subscribers only.
Takeda Pharmaceutical Co.’s diabetes drug Actos causes as many heart problems as Avandia, the GlaxoSmithKline Plc pill that had a decline in sales after being linked to higher heart-disease rates, a study found.
Patients taking Avandia or Actos were 4 percent more likely to experience heart attacks, heart failure or die, according to the study published yesterday in the American Heart Association journal, Circulation.